Article Details

GoodRx (NASDAQ:GDRX) Given New $10.50 Price Target at Morgan Stanley - Defense World

Retrieved on: 2022-05-20 15:49:39

Tags for this article:

Click the tags to see associated articles and topics

GoodRx (NASDAQ:GDRX) Given New $10.50 Price Target at Morgan Stanley - Defense World. View article details on hiswai:

Excerpt

The firm currently has an “equal weight” rating on the stock. Morgan Stanley's target price indicates a potential upside of 30.43% from the stock's ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up